HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
LJP 1082
a beta-cell toleragen for antiphospholipid syndrome; consists of four copies of recombinant domain I of beta2-glycoprotein I attached to a 20-kDa PEG platform via short linkers
Also Known As:
LJP-1082; LJP1082
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Carbohydrates: 22023
Glycoconjugates: 1353
Glycoproteins: 24834
LJP 1082: 1
Amino Acids, Peptides, and Proteins: 1
Proteins: 484843
Glycoproteins: 24834
LJP 1082: 1
Organic Chemicals: 133
Alcohols: 595
Glycols: 38
Ethylene Glycols: 8
Polyethylene Glycols: 3865
LJP 1082: 1
Macromolecular Substances: 97
Polymers: 13051
Polyethylene Glycols: 3865
LJP 1082: 1
Biomedical and Dental Materials
Polymers: 13051
Polyethylene Glycols: 3865
LJP 1082: 1
Technology, Industry, and Agriculture
Manufactured Materials
Biomedical and Dental Materials
Polymers: 13051
Polyethylene Glycols: 3865
LJP 1082: 1
Experts
1.
Merrill, J T
: 1 article (01/2004)
Related Diseases
1.
Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/01/2004 - "
LJP 1082: a toleragen for Hughes syndrome.
"